Fundraising Fox
Tevard Biosciences
Boston, US · 29 employees on LinkedIn · 3 known investors
Find your way into Tevard Biosciences
Sign up to see every warm intro you have to Tevard Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tevard Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.
Founders & leadership
HL
Harvey Lodish
DF
Daniel FischerCo-Founder, President and CEO, Board MemberDaniel Fischer is co-founder and CEO of Tevard Biosciences, which develops tRNA-based therapies for rare genetic diseases caused by nonsense mutations. He brings experience in innovation, growth management, and focus on genetic disease treatment.
WL
Warren LammertCo-Founder and Chairman of the BoardWarren Lammert is a co-founder and chairman of Tevard Biosciences, which develops tRNA-based therapies for rare genetic diseases including epilepsy and muscular dystrophy. He holds degrees from Yale University and the London School of Economics, founded Boston-based investment firm Granite Point Capital in 2004, and has spent two decades supporting epilepsy research through board roles at multiple therapeutic companies and co-founding epilepsy.com and the Epilepsy Therapy Project.
HL
Harvey Lodish, Ph.D.Co-Founder, Chair of the SAB, and Board Member
JC
Jeffery Coller, Ph.D.Scientific Co-Founder, Scientific Advisor
Investors · 3
CWRU Technology Ventureslisted by CWRU Technology VenturesCleveland · $50K – $250K
How we know: CWRU Technology Ventures's portfolio page · Not right? Tell us
Good Growth Capitallisted by Good Growth CapitalCharleston
How we know: Good Growth Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 2
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Tevard Biosciences.
Frequently asked questions
- What does Tevard Biosciences do?
- Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.
- Who founded Tevard Biosciences?
- Tevard Biosciences was founded by Harvey Lodish, Daniel Fischer, Warren Lammert, Harvey Lodish, Ph.D., Jeffery Coller, Ph.D..
- Who are Tevard Biosciences's investors?
- Tevard Biosciences's investors include CWRU Technology Ventures, Good Growth Capital, Lauder Partners.
- Where is Tevard Biosciences headquartered?
- Tevard Biosciences is headquartered in Boston, US.